Appendix I Derivation of transition matrix, transition probabilities, and the likelihood function for the disease natural history model The five-state model is depicted as follows: 12 NDR 23 34 BDR PPDR (State 2) (State 3) 45 PDR Blindness (State 1) (State 4) (State 5) Let ij represent the instantaneous progression rate from state i to state j . As in traditional stochastic processes, the movement between states is denoted by the following intensity matrix : 1 1 - 12 2 0 Previous Q 3 0 state 4 0 5 0 Current state 2 3 12 - 23 0 0 0 0 23 34 0 0 4 5 0 0 45 0 34 - 45 0 0 0 0 Let d1, d2, d3, d4 and d5 (d1=0, d 2 12 , d 3 23 , d 4 34 , d 5 45 ) be the eigenvalues of Q. The right eigenvector corresponding to d is denoted as A with 55 matrix. Thus Q A D A1 (A -1) where D=diag(d1, d2, d3, d4, d5). It should be noted that due to the Markov property the inverse of λ23, λ34, λ 45 gives average dwelling times staying at BDR, PPDR, and PDR, respectively. Assuming Q follows a time-homogeneous Markov model, the transition probabilities following Kalbfleisch and Lawless method1 are given by Pt A d i a egd1t , e d 2t , e d3t , e d 4t , e d5t A 1 (A - 2) subject to P(0)=1. The matrix of transition probabilities is denoted as follows: Current state 1 2 3 1 P11 t P12 t P13 t 2 0 P22 t P23 t Previous 3 0 0 P33 t state 4 0 0 0 5 0 0 0 4 5 P14 t P15 t P24 t P25 t P34 t P35 t P44 t P45 t 0 1 For calculation of transition probabilities, see Chen et al2. 1 Kalbfleisch D, Lawless JF. The analysis of panel data under a Markov assumption. J Am Stat Assoc 1985;80: 863-871. 2 Chen THH, Kuo HS, Yen MF, et al. Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics 2000; 56: 167-172. Transition probabilities in the above represent the probability of progressing from one state to another state. For example, the risk of transition from DM without DR to blindness during a five-year period is denoted by P15(5). Given these transition probabilities, one can develop the likelihood function based on the above retrospective cohort. Let n1, n2, n3 and n4 denote the number of NDR, BDR, PPDR and PDR, respectively. The likelihood function given this information is: 1 2 3 P11 (ma ) P (m ) P (m ) P (m ) 12 b 13 c 14 c a 1 b 1 c 1 d 1 1 P15 ( m a ) 1 P15 (mb ) 1 P15 (mc ) 1 P15 (mc ) n1 n2 n3 n4 4 (A -3) where ma, mb, mc and md represents age at first examination, and i is index variable for individual in state i. It should be noted that the probabilities in the parenthesis of the above expression (A-3) are conditional probabilities because there is no possibility of receiving fundus examination if subjects have suffered from blindness. This means that subjects with blindness at baseline are truncated from our retrospective cohort. Appendix II Derivation of transition matrix, transition probabilities, and the likelihood function for the intervention model In clinical reality, patients may regress to DM without DR after clinical control or treatment. The evolution of DR may be delineated as follows: λc21 λc32 NDR BDR PPDR PDR Blindness λc12 λc23 λc34 λc45 Similarly, the transition model under clinical control or treatment is denoted by the following matrix : 1 1 - C 12 2 C 21 Previous Q 3 0 state 4 0 5 0 Current state 2 3 C 12 0 C C C - 21 23 23 C 32 C 32 C 34 0 0 0 0 4 5 0 0 C 45 0 C 34 - C 45 0 0 0 0 The likelihood function of this model can be derived in the same way as above. Suppose successive transitions following initial state Yi(t) (Y(t)=1,2,3,4 or 5) at first examination is observed intermittently at times ti ,0 ti ,1 , ti.mi 1 ti.mi , i 1,......, n individual and the states observed at these times are y i 0 , y i1 ,... y i mi The likelihood function for this part is: n mi i 1 d 1 (P y i d 1 . y i d (t i.d t i.d 1 )) (A -4) Note that a similar model was also developed while right-censoring due to death was taken into account. Also note that as seen in the equation (A-4), our model can accommodate irregular intervals because individual intervals were modeled to estimate transition rates.